A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: Primary results of the ARISE trial

被引：0
|
作者：
Ashina, M. [1 ,2 ]
Dodick, D. [3 ]
Kudrow, D. [4 ]
Lanteri-Minet, M. [5 ,6 ]
Osipova, V.
Palmer, K. [7 ]
Picard, H. [8 ]
Mikol, D. [8 ]
Lenz, R. [8 ]
机构：
[1] Univ Copenhagen, Danish Headache Ctr, Rigshosp Glostrup, Fac Med & Hlth Sci, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Neurol, Rigshosp Glostrup, Fac Med & Hlth Sci, Copenhagen, Denmark
[3] Mayo Clin, Scottsdale, AZ USA
[4] Calif Med Clin Headache, Santa Monica, CA USA
[5] CHU, Pain Dept, Nice, France
[6] CHU, FHU InovPain, Nice, France
[7] Amgen Inc, Cambridge, England
[8] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PR1045
引用
收藏
页码：470 / 470
页数：1
相关论文
共 50 条
  • [31] Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Sonbolestan, Seyed Ali
    Heshmat, Kiyan
    Javanmard, Shaghayegh Haghjooy
    Saadatnia, Mohammad
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2013, 4 (01) : 72 - 77
  • [32] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [33] A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
    Yiannakou, Yan
    Piessevaux, Hubert
    Bouchoucha, Michel
    Schiefke, Ingolf
    Filip, Rafal
    Gabalec, Libor
    Dina, Ion
    Stephenson, David
    Kerstens, Rene
    Etherson, Kevin
    Levine, Amy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (05): : 741 - 748
  • [34] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [35] A Randomized, Double-Blind, Placebo-Controlled Study of Erenumab Safety in Patients with Stable Angina
    Depre, C.
    Antalik, L.
    Starling, A. J.
    Koren, M.
    Eisele, O.
    Mikol, D.
    HEADACHE, 2018, 58 : 177 - 177
  • [36] Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
    Sun, Hong
    Dodick, David W.
    Silberstein, Stephen
    Goadsby, Peter J.
    Reuter, Uwe
    Ashina, Messoud
    Saper, Joel
    Cady, Roger
    Chon, Yun
    Dietrich, Julie
    Lenz, Robert
    LANCET NEUROLOGY, 2016, 15 (04): : 382 - 390
  • [37] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [38] Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for Migraine Prevention in Pediatric Subjects 12 to 17 Years of Age
    Lewis, Donald
    Winner, Paul
    Saper, Joel
    Ness, Seth
    Polverejan, Elena
    Wang, Steven
    Kurland, Caryn L.
    Nye, Jeff
    Yuen, Eric
    Eerdekens, Marielle
    Ford, Lisa
    PEDIATRICS, 2009, 123 (03) : 924 - 934
  • [39] A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age
    Lewis, Donald
    Winner, Paul
    Saper, Joel
    Ness, Seth
    Polverejan, Elena
    Kurland, Caryn
    Ford, Lisa
    Eerdekens, Marielle
    NEUROLOGY, 2008, 70 (11) : A426 - A426
  • [40] A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age
    Lewis, D.
    Winner, P.
    Saper, J.
    Ness, S.
    Polverejan, E.
    Kurland, C.
    Ford, L.
    Eerdekens, M.
    HEADACHE, 2008, 48 : S8 - S9
12345